Investor Day to be held in New York on March 19 at 9 am. Webcast LinkLight Up your Portfolio with Spark:Easily identify stocks' risks and ...
Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...
At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will discuss ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday ...
Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...
Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...
Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...
Hosted on MSN1mon
Why Quest Diagnostics Stock Was Blasting Higher TodayQuest Diagnostics ... in the day. The main reason for the bullish move wasn't hard to figure out -- Quest posted its fourth-quarter and full-year 2024 results this morning. Investors were ...
This was the stock's second consecutive day of losses.
Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...
Quest Diagnostics Inc. closed 2.79% short of its 52-week high of $178.09, which the company reached on March 3rd.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback